A Phase II/III Study of IBB0979 in Combination With Topotecan Versus Topotecan in Relapsed Small Cell Lung Cancer

by | Jul 21, 2025 | Clinical Trials | 0 comments

​ Conditions: Small Cell Lung Cancer

Interventions: Drug: IBB0979; Drug: topotecan hydrochloride for injection

Sponsors: SUNHO（China）BioPharmaceutical CO., Ltd.; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital

Not yet recruiting Conditions: Small Cell Lung Cancer
Interventions: Drug: IBB0979; Drug: topotecan hydrochloride for injection
Sponsors: SUNHO（China）BioPharmaceutical CO., Ltd.; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *